Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WLF Appeal Could Receive Hearing By Spring 2000 Under FDA Expedited Plan

Executive Summary

The Washington Legal Foundation will challenge FDA's request for an expedited appeal to D.C. District Court Judge Royce Lamberth's July 28 ruling invalidating the off-label dissemination provisions of the FDA Modernization Act, WLF Chief Counsel Richard Samp told a Food & Drug Law Institute conference in Bethesda, Md. Sept. 13.

You may also be interested in...



WLF Ruling Offers No Viable Alternatives For Encouraging sNDAs - FDA Appeal

The ruling overturning FDA's regulation of off-label reprint dissemination offers no viable alternatives for encouraging companies to file supplemental new drug applications, FDA's appeal of Washington Legal Foundation v. Henney argues.

WLF Ruling Offers No Viable Alternatives For Encouraging sNDAs - FDA Appeal

The ruling overturning FDA's regulation of off-label reprint dissemination offers no viable alternatives for encouraging companies to file supplemental new drug applications, FDA's appeal of Washington Legal Foundation v. Henney argues.

Pharmacoeconomic Promotion May Change Less Than Expected - Perfetto

The healthcare economic claim provisions of the FDA Modernization Act may not change the pharmacoeconomic promotion environment as much as had initially been anticipated, QualityMetric Exec VP Eleanor Perfetto, PhD, reported to a Pharmaceutical Education and Research Institute meeting in Baltimore, Md. Sept. 30.

Related Content

UsernamePublicRestriction

Register

PS034860

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel